Publications

Our publications

Citation

T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.

Breast Cancer Res Treatment . 2013 Jun 08 ; 139(3) 657 | DOI : 10.1007/s10549-013-2577-z

  • DL. Cecil
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

Clin Cancer Res . 2013 Dec 09 ; 20(5) 1125 | DOI : 10.1158/1078-0432.CCR-13-2147

  • DA. Wick
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15–dependent DC crosstalk.

J Immunol . 2014 Jul 30 ; 93(5) 2297 | DOI : 10.4049/​jimmunol.1400489.

  • K. Sehgal
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+ T cells targeting AMA1 class I epitopes.

PloS One . 2014 Sep 11 ; 9(9) e106241 | DOI : 10.1371/journal.pone.0106241.

  • M. Sedegah
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Memory phenotypes of HIV-specific CD8+ T cell responses are independent of functional activity as defined by cytokine output.

Open J Immunol . 2014 Sep 01 ; 4(3) 83 | DOI : 10.4236/oji.2014.43012.

  • ME. Richmond
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Sprouty-2 regulates HIV-specific T cell polyfunctionality.

J Clin Invest . 2014 Jan 01 ; 124(1) 198 | DOI : 10.1172/JC170510.

  • YL. Chiu
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.

Int J Cancer . 2016 Mar 08 ; 139(1) 122 | DOI : 10.1002/ijc.30046.

  • D. Upreti
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Cryopreservation of Human Mucosal Leukocytes.

PLoS One . 2016 May 27 ; 11(5) e0156293 | DOI : 10.1371/journal.pone.0156293.

  • SM. Hughes

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.

PLoS Pathog . 2017 Feb 24 ; 13(2) e1006232 | DOI : 10.1371/journal.ppat.1006232.

  • N. Bhattarai
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025

Citation

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

J Hematol Oncol . 2017 Apr 07 ; 10(1) 82 | DOI : 10.1186/s13045-017-0459-2.

  • S. Mehrotra
  • et al

Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025